The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs' original purpose, which was to treat Type 2 diabetes, a new study ... use as a weight-loss ...

Semaglutide did not increase the risk of depression, suicidal thoughts or suicidal behavior in people without known mental ...

Related Study shows shift in GLP-1 drug use for obesity, not diabetes Weight loss drug Zepbound outperforms Ozempic in new ...

The researchers found that GLP-1 RA use was associated with a lower rate of any hyperkalemia and moderate-to-severe hyperkalemia compared with DPP-4i use (hazard ratios, 0.61 and 0.52, respectively).

In patients with type 2 diabetes (T2D), the use of glucagon ... The study included 33,280 patients with T2D (mean age, 63.7 years; 59.7% men) who were new users of any GLP-1 RA or DPP-4i between ...

A new observational study found ... class of GLP-1 diabetes and obesity drugs. Academic researchers analyzed a World Health Organization database that tracks suspected adverse drug reactions ...

"The growth of GLP-1 agonists to treat obesity has been incredible and highly effective in the short run, but data shows that 67% of patients discontinue use due ... The study is designed to ...

Share on Pinterest A new study found a link ... between semaglutide use and suicidal thoughts. More research in this area is needed since studies on GLP-1 drug use and suicidal ideation have ...

There’s a new twist in the ongoing debate over whether drugs widely used for weight loss are linked with thoughts of self-injury or suicide. Use of semaglutide, the active ingredient in Novo ...